Distribution, Genetic Diversity and Biocontrol of Aflatoxigenic Aspergillus flavus in Serbian Maize Fields.
Vanja VlajkovMila GrahovacDragana BudakovMarta LocIvana PajčinDragan MilićTihomir NovakovićJovana GrahovacPublished in: Toxins (2021)
Maize is one of the leading export products in the Republic of Serbia. As a country where economic development depends on agriculture, maize production plays a critical role as a crop of strategic importance. Potential aflatoxin contamination of maize poses a risk to food and feed safety and tremendous economic losses. No aflatoxin contamination of maize samples harvested in 2019 and 2020 in different localities in the Republic of Serbia was detected by the Enzyme-Linked Immunosorbent Assay (ELISA) test and High-Performance Liquid Chromatography (HPLC) method. On the other hand, the Cluster Amplification Patterns (CAP) analyses of the isolated Aspergillus flavus strains from 2019 maize samples confirmed the presence of key biosynthesis genes responsible for aflatoxin production. Artificial inoculation and subsequent HPLC analysis of the inoculated maize samples confirmed the high capacity of the A. flavus strains for aflatoxin production, pointing to a high risk of contamination under favorable conditions. Prevention of aflatoxin contamination is primarily based on A. flavus control, where biocontrol agents play a significant role as sustainable disease management tools. In this study, antagonistic activity screening of the novel strains belonging to the Bacillus genus indicated superior suppression of A. flavus strains by two Bacillus strains isolated from the rhizosphere of Phaseolus vulgaris.
Keyphrases
- high performance liquid chromatography
- escherichia coli
- risk assessment
- human health
- drinking water
- simultaneous determination
- ms ms
- health risk
- mass spectrometry
- genetic diversity
- tandem mass spectrometry
- climate change
- solid phase extraction
- genome wide
- high throughput
- dna methylation
- cell wall
- liquid chromatography
- high resolution
- monoclonal antibody